Chandy KG[au] - Search Results

Year	Number of Results
1979	1
1980	3
1981	3
1982	1
1983	3
1984	4
1985	5
1986	2
1987	5
1988	3
1989	1
1990	4
1991	1
1992	3
1993	4
1994	2
1996	3
1997	3
1998	9
1999	7
2000	3
2001	8
2002	3
2003	7
2004	6
2005	5
2006	1
2007	10
2008	4
2009	4
2010	1
2011	4
2012	5
2013	4
2014	2
2016	2
2017	7
2018	1
2019	2
2020	3
2021	2
2022	2

1

Contributions of natural products to ion channel pharmacology.

Bajaj S, Ong ST, Chandy KG. Bajaj S, et al. Among authors: chandy kg. Nat Prod Rep. 2020 May 1;37(5):703-716. doi: 10.1039/c9np00056a. Epub 2020 Feb 17. Nat Prod Rep. 2020. PMID: 32065187 Review.

2

Venom-derived peptide inhibitors of voltage-gated potassium channels.

Norton RS, Chandy KG. Norton RS, et al. Among authors: chandy kg. Neuropharmacology. 2017 Dec;127:124-138. doi: 10.1016/j.neuropharm.2017.07.002. Epub 2017 Jul 5. Neuropharmacology. 2017. PMID: 28689025 Review.

3

Antibodies and venom peptides: new modalities for ion channels.

Wulff H, Christophersen P, Colussi P, Chandy KG, Yarov-Yarovoy V. Wulff H, et al. Among authors: chandy kg. Nat Rev Drug Discov. 2019 May;18(5):339-357. doi: 10.1038/s41573-019-0013-8. Nat Rev Drug Discov. 2019. PMID: 30728472 Free PMC article. Review.

4

Ion channels in lymphocytes.

Chandy KG, DeCoursey TE, Cahalan MD, Gupta S. Chandy KG, et al. J Clin Immunol. 1985 Jan;5(1):1-6. doi: 10.1007/BF00915161. J Clin Immunol. 1985. PMID: 2579969 Review.

5

Structures of wild-type and H451N mutant human lymphocyte potassium channel K_V1.3.

Liu S, Zhao Y, Dong H, Xiao L, Zhang Y, Yang Y, Ong ST, Chandy KG, Zhang L, Tian C. Liu S, et al. Among authors: chandy kg. Cell Discov. 2021 Jun 1;7(1):39. doi: 10.1038/s41421-021-00269-y. Cell Discov. 2021. PMID: 34059645 Free PMC article. No abstract available.

6

Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases.

Chi V, Pennington MW, Norton RS, Tarcha EJ, Londono LM, Sims-Fahey B, Upadhyay SK, Lakey JT, Iadonato S, Wulff H, Beeton C, Chandy KG. Chi V, et al. Among authors: chandy kg. Toxicon. 2012 Mar 15;59(4):529-46. doi: 10.1016/j.toxicon.2011.07.016. Epub 2011 Aug 12. Toxicon. 2012. PMID: 21867724 Free PMC article. Review.

7

Therapeutic potential of peptide toxins that target ion channels.

Beraud E, Chandy KG. Beraud E, et al. Among authors: chandy kg. Inflamm Allergy Drug Targets. 2011 Oct;10(5):322-42. doi: 10.2174/187152811797200696. Inflamm Allergy Drug Targets. 2011. PMID: 21745182 Review.

8

Kv1.3 Channel Up-Regulation in Peripheral Blood T Lymphocytes of Patients With Multiple Sclerosis.

Markakis I, Charitakis I, Beeton C, Galani M, Repousi E, Aggeloglou S, Sfikakis PP, Pennington MW, Chandy KG, Poulopoulou C. Markakis I, et al. Among authors: chandy kg. Front Pharmacol. 2021 Sep 23;12:714841. doi: 10.3389/fphar.2021.714841. eCollection 2021. Front Pharmacol. 2021. PMID: 34630091 Free PMC article.

9

Immunology: Channelling potassium to fight cancer.

Chandy KG, Norton RS. Chandy KG, et al. Nature. 2016 Sep 22;537(7621):497-499. doi: 10.1038/nature19467. Epub 2016 Sep 14. Nature. 2016. PMID: 27626384 No abstract available.

10

Peptide blockers of K_v1.3 channels in T cells as therapeutics for autoimmune disease.

Chandy KG, Norton RS. Chandy KG, et al. Curr Opin Chem Biol. 2017 Jun;38:97-107. doi: 10.1016/j.cbpa.2017.02.015. Epub 2017 Apr 14. Curr Opin Chem Biol. 2017. PMID: 28412597 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results